Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 20, 2010
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2010, as well as guidance for net...
-
Jul 8, 2010
Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in its MultiSENSE clinical trial. The trial is designed to...
-
Jul 7, 2010
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2010...
-
Jun 24, 2010Two new splitters allow multi-site placement of up to four spinal cord stimulation leads
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration approval and launch of two spinal cord stimulation...
-
Jun 23, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the successful syndication of a new $1 billion, three-year term loan and a new $2...
-
Jun 21, 2010Longer balloons provide physicians more options for treating peripheral artery disease
Boston Scientific Corporation (NYSE: BSX) today announced that 22 new balloon sizes have been added to the PolarCath® Peripheral Dilatation...
-
Jun 18, 2010
Boston Scientific Corporation (NYSE: BSX) today announced results from a sub-analysis of the MADIT-CRT trial data that showed...
-
Jun 14, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wells Fargo Healthcare Conference on June 24th in Boston. Ray Elliott,...
-
Jun 11, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's key events and sponsored research at the 17th Cardiostim...
-
Jun 10, 2010CE Mark approval includes specific indication for treatment of diabetic patients
Boston Scientific Corporation (NYSE: BSX) today announced the market launch and first implants of its TAXUS® Element™ Paclitaxel-Eluting...